reports
- ABGSC Seafood Research
- Martin Kaland
- Simon Brun
- ABGSC Seafood Research
- Martin Kaland
- Simon Brun
Lexicon Pharmaceuticals to Announce Topline Results from Phase 2b PROG...
Lexicon Pharmaceuticals to Announce Topline Results from Phase 2b PROGRESS Study Evaluating Pilavapadin (LX9211) in Adults with Diabetic Peripheral Neuropathic Pain Conference call and webcast at 8:00 a.m. ET on Monday, March 3, 2025 THE WOODLANDS, Texas, March 02, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced the Company will hold a conference call and webcast on Monday, March 3, 2025 at 8:00 a.m. ET to share topline results from the Phase 2b PROGRESS (A Phase 2b, Dose-ranging, Randomized, Double-blind, PlacebO-controlled, Parallel-GRoup, MulticE...
- ABGSC Seafood Research
- Martin Kaland
- Simon Brun
- ABGSC Oil & Oil Services Research
- Njål Kleiven
- Stian Wibstad
- ABGSC IT Research
- Daniel Thorsson
- Simon Granath
- ABGSC Shipping & Transport Research
- Martin Mauseth
- Petter Haugen
- ABGSC Energy Research
- Haakon Amundsen
- John Olaisen
- Njål Kleiven
- Oliver Dunvold
- Stian Wibstad
Initial Drill Results Prove Significant Polymetallic Mineralization at...
Initial Drill Results Prove Significant Polymetallic Mineralization at Mirasol’s Flagship Sobek Gold-Copper Project in the Vicuña District, Chile Initial drilling of the Potro SE target on Sobek North intersected a new polymetallic mineralized system: 17.4m at 0.72g/t gold Eq. including 3.0m at 2.39 g/t gold Eq and high silver, lead, zinc with indications of copperThe drill hole ended in strongly altered porphyritic rock and the system remains open laterally and at depthThe mineralized intercept is directly associated with a large IP-PDP geophysical chargeability response which underlies a ...
Nokia and industry partners accelerate AI-RAN development #MWC25
Nokia and industry partners accelerate AI-RAN development #MWC25 Press ReleaseNokia and industry partners accelerate AI-RAN development #MWC25 Nokia’s ecosystem of industry partnerships is driving advancements in AI-RAN architecture and the deployment and optimization of AI-powered Radio Access Networks. Collaboration helps lay the foundations for platform-as-a-service business models for operators offering scalable computing infrastructure and capabilities for AI and other services in addition to connectivity. Nokia opens AI-RAN Center in Dallas, U.S to accelerate development of AI-RAN w...
Merus gibt Finanzergebnisse für das vierte Quartal und das Gesamtjahr ...
Merus gibt Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2024 bekannt und berichtet über die Geschäftsentwicklung - Phase-III-Zulassungsstudien zu Petosemtamab in Kombination mit Pembrolizumab in der Erstlinienbehandlung des PD-L1-positiven rezidivierten/metastasierten Kopf-Hals-Plattenepithelkarzinoms (r/m HNSCC) und Petosemtamab als Monotherapie in der Zweit-/Drittlinienbehandlung des r/m HNSCC nehmen Patienten auf; die Rekrutierung soll bis Ende 2025 weitgehend abgeschlossen sein - Phase-II-Studie mit Petosemtamab in Kombination mit Pembrolizumab in der Erstlinienbehandlung...
Merus annonce les résultats financiers de son quatrième trimestre et d...
Merus annonce les résultats financiers de son quatrième trimestre et de l’ensemble de son exercice 2024, et fait le point sur ses activités - Inclusion en cours pour les études d’enregistrement de phase III visant l’évaluation du pétosemtamab en association avec le pembrolizumab en traitement de 1ᵉ ligne pour un CETC r/m PD-L1 et l’évaluation du pétosemtamab en monothérapie de 2ᵉ et 3ᵉ ligne contre le CETC r/m ; recrutement pressenti terminé en grande partie d’ici fin 2025 - Essai de phase II portant sur le pétosemtamab en association avec le pembrolizumab en 1ᵉ ligne de traitement dans le...
Notification of transaction by an Officer of Millicom (Tigo)
Notification of transaction by an Officer of Millicom (Tigo) Notification of transaction by an Officer of Millicom (Tigo) Luxembourg, March 1, 2025 – International Cellular S.A. ("Millicom" or the “Company”) announces that, on February 27, 2025, under an existing 10b5-1 plan, Mr. Salvador Escalon, Chief Legal and Compliance Officer, sold 10,991 Millicom shares in the open market at an average price of $28.8473 per share. As a result, Salvador Escalon currently owns 151,410 shares. Details of the transaction are recorded on the personal trading section of Millicom’s . For further info...
Jasper Therapeutics Presents Clinical and Preclinical Briquilimab Data...
Jasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting REDWOOD CITY, Calif., March 01, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit to address mast cell driven diseases such as chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU) and asthma, is presenting updated clinical data from the Phase 1b/2a BEACON study, as well as dat...
Celldex Therapeutics Presents Positive Results from Barzolvolimab Phas...
Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025 - Greatly improved patient quality of life and reduced disease impact in patients with CSU and CIndU -- 82% of CSU patients reported that symptoms no longer had an impact on their quality of life at Week 52 -- 60% of CIndU patients reported that symptoms no longer had an impact on their quality of life at Week 12 - HAMPTON, N.J., March 01, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CL...
Shenzhen Tongyi Industry Co Ltd: 1 director
A director at Shenzhen Tongyi Industry Co Ltd sold 284,000 shares at 15.073CNY and the significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...
Dominion Lending Centres Inc: 2 directors
Two Directors at Dominion Lending Centres Inc sold 7,782,400 shares at 7.600CAD. The significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...
Monument veröffentlicht Finanzergebnisse für das zweite Quartal 2025
Monument veröffentlicht Finanzergebnisse für das zweite Quartal 2025 Bruttoeinnahmen von 19,80 Millionen US-Dollar und Barmittelkosten von 918 US-Dollar je Unze VANCOUVER, British Columbia, March 01, 2025 (GLOBE NEWSWIRE) -- Monument Mining Limited (TSX-V: MMY und FSE: D7Q1) „Monument“ oder das „Unternehmen“ gab heute seine Finanzergebnisse für die drei Monate („Q2 GJ 2025“) und die sechs Monate bis zum 31. Dezember 2024 („YTD GJ 2025“) bekannt. Alle Beträge sind in US-Dollar angegeben, sofern nichts anderes vermerkt ist (siehe für die vollständigen Finanzergebnisse). Präsidentin und ...
Monument publie les résultats financiers de son deuxième trimestre 202...
Monument publie les résultats financiers de son deuxième trimestre 2025 Chiffre d’affaires brut de 19,80 millions USD et coût décaissé de 918 USD par once VANCOUVER, Province de Colombie-Britannique, 01 mars 2025 (GLOBE NEWSWIRE) -- Monument Mining Limited (TSX-V : MMY et FSE : D7Q1), ci-après « Monument » ou la « Société », publie ce jour ses résultats financiers pour les trois mois et les six mois clos le 31 décembre 2024, respectivement le « deuxième trimestre » et le « cumul annuel » de l’exercice 2025. Sauf indication contraire, tous les montants sont exprimés en dollars américains...
Raketech Group Holding: 1 director
A director at Raketech Group Holding bought 70,000 shares at 3.450SEK and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.